The European Commission’s proposals to extend the transition deadlines for legacy products in the context of the Medical Device Regulation and remove the sell-off date for products under both the MDR and In Vitro Diagnostics Regulation were adopted formally by the EU Council during a meeting on 7 March.
The unanimous vote by all 27 member states took place during a meeting of the Council of the European Union on Education, Youth, Culture and Sport, in Brussels.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?